Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,767.60
(
-1.51%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.25
(
1.56%
)
Bitcoin
70,881.33
(
-0.51%
)
News Focus
News Focus

Replies to post #15890 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #15890 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

DewDiligence

09/01/16 3:09 PM

#15891 RE: t57 #15890

MNTA's 40mg-Copaxone ANDA already has a 2016 decision date, so it doesn't need additional prioritization.